Cdg Biotech

FDA Filings

This page includes the latest FDA filings for Cdg Biotech. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)
Registration Number3013023580
FEI Number3013023580
NameCDG BIOTECH
Owner & OperatorCDG Biotech
Contact Address31332 Via Collinas, Unit 106
Westlake Village CA 91362 US
Registration Status1
Initial ImporterN
Registration Expiration2020-04-25
Registration Address31332 Via Colinas Ste 106
Westlake Village, CA 91362 US
Establishment Type
  • Manufacture Device in the United States for Export Only
  • Develop Specifications But Do Not Manufacture At This Facility

FDA Filings

Device
Company
DeviceDate
CDG BIOTECH
CDG Biotech Q-Strip T32020-04-04
CDG BIOTECH
CDG Biotech Q-Strip FT32020-04-04
CDG BIOTECH
CDG Q-Strip 17-OH Progesterone x 24 Tests2019-04-03
CDG BIOTECH
CDG Q-Strip C-Peptide x 24 Tests2019-04-03
CDG BIOTECH
CDG Q-Strip ANDROSTENEDIONE x 24 Tests2019-04-03
CDG BIOTECH
CDG Q-Strip Insulin x 24 Tests2019-04-03
CDG BIOTECH
CDG Q-STRIP HGH (Human Growth Hormone)2019-04-02
CDG BIOTECH
CDG Q-Strip DHEA, DHEA-S DEHYDROEPIANDROSTERONE (FREE AND SULFATE) x 24 tests2018-10-27

Related Finance Registrations
© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.